Skip to main content

Table 1 Experimental groups and content of IP injections received as treatments

From: Diabetic encephalopathy: beneficial effects of supplementation with fatty acids ω3 and nordihydroguaiaretic acid in a spontaneous diabetes rat model

Rat strain

Group name

Treatment (0.4 ml IP)

eSS

Control eSS

Diabetic control. Only saline isotonic solution

eSS

ω6

Saline isotonic solution plus 6.25 mg/kg of 90% AA

eSS

ω6 + NDGA

Saline isotonic solution plus 6.25 mg/kg of 90% AA oil + 1.19 mg/kg NDGA

eSS

ω3

Saline isotonic solution plus 6.25 mg/kg of commercial fish oil containing 35% eicosapentaenoic acid (EPA) and 40% docosahexaenoic acid (DHA)

eSS

ω3 + NDGA

Saline isotonic solution plus 6.25 mg/kg of commercial fish oil + 1.19 mg/kg NDGA

Wistar

Wistar

Non- diabetic control. Only saline isotonic solution